一个患有严重呼吸衰竭和右心衰竭的患者的皮肤穿OxyRVAD:一个病例报告
Ga Young Yoo1, June Lee1, Seok Beom Hong1
1Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
在VV ECMO治疗的严重呼吸衰竭患者可能会患上右心力衰竭. 通过皮肤注射的氧化右心室辅助装置 (OxyRVAD) 成功处理了这种并发症,维持了血液流动并防止了右心室应变.
科学领域:
- 心脏病学 心脏病学
- 心胸外科手术 心胸外科手术
- 肺部病理学 肺部病理学
背景情况:
- 静脉外体膜氧化 (VV ECMO) 是严重呼吸衰竭的关键治疗方法,通常是在肺移植之前进行的.
- 右心力衰竭是严重肺病患者的重要并发症,在VV ECMO期间提出治疗挑战.
- 在VV ECMO患者中,对右心力衰竭的现有管理策略可能是复杂的.
更多相关视频
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
相关概念视频
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV
Acute Respiratory Failure-III
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
